The spread of fungi resistant to conventional drugs has become a threatening problem. In
this context, antimicrobial peptides (AMPs) have been considered as one of the main …

Candida yeast infections are the fourth leading cause of death worldwide. Peptides with
antimicrobial activity are a promising alternative treatment for such infections. Here, the …

Antimicrobial peptides (AMP) represent an alternative in the treatment of fungal infections
associated with countless deaths. Here, we report a new AMP, named KWI-19, which was …

The rapid increase in the emergence of antifungal-resistant Candida albicans strains is
becoming a serious health concern. Because antimicrobial peptides (AMPs) may provide a …

Antimicrobial peptides (AMPs) represent a promising class of therapeutic biomolecules that
show antimicrobial activity against a broad range of microorganisms, including life …

Abstract Background Antimicrobial peptides (AMPs) are molecules with potential application
for the treatment of microorganism infections. We, herein, describe the structure, activity, and …

Candida albicans is a major cause of human infections, ranging from relatively simple to
treat skin and mucosal diseases to systemic life-threatening invasive candidiasis. Fungal …

Background Cryptococcus neoformans is a common human fungal pathogen in
immunocompromised people, as well as a prevalent cause of meningitis in HIV-infected …

Anionic antimicrobial peptides constitute an integral component of animal innate immunity,
however the mechanisms of their antifungal activity are still poorly understood. The action of …

Invasive fungal infections caused by opportunistic fungal pathogens are associated with
high mortality rates, mainly due to the occurrence of genotypic and/or phenotypic resistance …